145 related articles for article (PubMed ID: 17225049)
1. CT-based postimplant dosimetry of prostate brachytherapy: comparison of 1-mm and 5-mm section CT.
Tanaka O; Hayashi S; Kanematsu M; Matsuo M; Nakano M; Maeda S; Deguchi T; Hoshi H
Radiat Med; 2007 Jan; 25(1):22-6. PubMed ID: 17225049
[TBL] [Abstract][Full Text] [Related]
2. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy.
Solhjem MC; Davis BJ; Pisansky TM; Wilson TM; Mynderse LA; Herman MG; King BF; Geyer SM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):767-76. PubMed ID: 15465193
[TBL] [Abstract][Full Text] [Related]
3. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
5. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
6. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
[TBL] [Abstract][Full Text] [Related]
7. MR and CT image fusion for postimplant analysis in permanent prostate seed implants.
Polo A; Cattani F; Vavassori A; Origgi D; Villa G; Marsiglia H; Bellomi M; Tosi G; De Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1572-9. PubMed ID: 15590189
[TBL] [Abstract][Full Text] [Related]
8. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
10. Impact of MRI-based postimplant dosimetric assessment in prostate brachytherapy using contrast-enhanced T1-weighted images.
Ohashi T; Momma T; Yamashita S; Nagatsuma K; Kanai K; Kitagawa K; Takahashi S; Hanada T; Yorozu A; Shigematsu N
Brachytherapy; 2012; 11(6):468-75. PubMed ID: 22330102
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
Aoki M; Yorozu A; Dokiya T
Jpn J Radiol; 2009 Nov; 27(9):342-7. PubMed ID: 19943144
[TBL] [Abstract][Full Text] [Related]
13. T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
Katayama N; Takemoto M; Yoshio K; Katsui K; Uesugi T; Nasu Y; Matsushita T; Kaji M; Kumon H; Kanazawa S
J Radiat Res; 2011; 52(5):680-4. PubMed ID: 21857148
[TBL] [Abstract][Full Text] [Related]
14. Effect of prostatic edema on CT-based postimplant dosimetry.
Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
[TBL] [Abstract][Full Text] [Related]
15. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
16. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of CT and MR-CT fusion for prostate post-implant dosimetry.
Maletz KL; Ennis RD; Ostenson J; Pevsner A; Kagen A; Wernick I
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1912-7. PubMed ID: 21550183
[TBL] [Abstract][Full Text] [Related]
18. The impact of postimplant edema on the urethral dose in prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):661-4. PubMed ID: 10837949
[TBL] [Abstract][Full Text] [Related]
19. Brachytherapy in patients with small prostate glands.
Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
[TBL] [Abstract][Full Text] [Related]
20. Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds.
Aoki M; Yorozu A; Dokiya T
Jpn J Radiol; 2009 Dec; 27(10):410-5. PubMed ID: 20035412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]